Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-24-076840)

Filing Details

Accession Number:: 0001104659-24-076840
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-07-01 16:24:38
Reporting Period:: 2024-06-28

Accepted Time:: 2024-07-01 16:24:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1401040	Diamedica Therapeutics Inc.	DMAC	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1887436	Ab Trill	C/O Trill Ab Sveavagen 17, 18Th Floor Stockholm V7 111 57		No	No	Yes	No
1983161	Jan Stahlberg	C/O Trill Ab Sveavagen 17, 18Th Floor Stockholm V7 111 57		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2024-06-28	1,200,000	$2.50	5,221,608	No	4	P	Indirect	See Footnote 1

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote 1

Footnotes

These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.